Novo Nordisk has reported the second phase 3 trial of its new obesity hopeful CagriSema but, as with the first, the topline ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Stock futures fell again Monday, after the S&P 500 had its worst week in months amid fears about President Donald Trump's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results